In case of downtime/other tech emergencies, you can relatively quickly get in touch with Asmodean Prime by email.
Started by Recusant, January 18, 2020, 08:56:00 PM
Quote from: Recusant on May 03, 2021, 08:48:10 AMThe creeps in Washington DC are making noises about putting a federal limit on potency. They haven't legalized it fer fuck's sake. You're going to put regulations on something you don't allow people to legally possess? Sounds like a non-starter to me, but then I don't have a politician's ability to get their cranium firmly inserted into their nether orifice. Bastards. I've never thought much of Feinstein, from her rise to power in San Francisco (taking over for the murdered Mayor Moscone) and on through her notably successful career. "The cannabis industry's next war: How strong should its weed be?" | PoliticoQuoteProposals to limit the potency of THC have been introduced by both Democrats and Republicans, and are likely to proliferate as the legal pot market expands and matures. Lawmakers in Congress have also expressed concern about the increasing potency of weed. In March, the co-chairs of the Senate Caucus on International Narcotics Control — Dianne Feinstein (D-Calif.) and John Cornyn (R-Texas) — argued that federal agencies should consider recommending THC caps.[Link to full article.]Forty-five years ago --
QuoteProposals to limit the potency of THC have been introduced by both Democrats and Republicans, and are likely to proliferate as the legal pot market expands and matures. Lawmakers in Congress have also expressed concern about the increasing potency of weed. In March, the co-chairs of the Senate Caucus on International Narcotics Control — Dianne Feinstein (D-Calif.) and John Cornyn (R-Texas) — argued that federal agencies should consider recommending THC caps.[Link to full article.]
Quote from: billy rubin on May 12, 2021, 10:30:35 AMeven asmall amount messes me up, magdalena. i have no physiological tolerance. the stuff to me is super unpleasant.its always been that way
QuoteThe anti-seizure qualities of the cannabis plant can likely not be boiled down to a single compound, like cannabidiol (CBD), according to emerging research.Studies in Australia have recently revealed numerous other compounds in the cannabis plant that also show anticonvulsant effects. Some of them could even be more powerful than CBD.A small observational study in the United Kingdom now backs up those findings. When 10 children with intractable forms of epilepsy began using a medicine that contained the whole cannabis plant, including cannabidiols, terpenes, and flavonoids, their seizure frequency fell by an average of 86 percent.The research was not randomized or placebo-controlled, however, these case studies show far greater success than the outcomes of CBD extracts alone.[Continues . . .]
QuoteAbstract:Objectives To report the findings of a case-series of 10 children suffering with intractable epilepsies in the UK to determine the feasibility for using whole-plant cannabis medicines to treat seizures in children.Setting This study was conducted retrospectively through collecting clinical data from caretakers and clinicians on study outcome variables. Participants were recruited through the MedCann Support and End our Pain charity groups which are patient representative groups that support children who are using medical cannabis to treat their epilepsies. Medicines were prescribed to patients by clinicians in both National Health Service and private medical practices. Follow-up calls were conducted throughout the period January 2021 to May 2021 to keep data recorded up to date.Participants Ten children, 18 years old or under, with intractable epilepsies were recruited from two charities. There were no limitations on diagnosis, sex or ethnic origin.Interventions Participants were treated with a range of whole-plant medical cannabis oils. Individual dosing regimens were determined by clinicians.Primary outcome measure The primary outcome measure was seizure frequency.Results Seizure frequency across all 10 participants reduced by 86% with no significant adverse events. Participants reduced use of antiepileptic drugs from an average of seven to one following treatment with medical cannabis. We also noted significant financial costs of £874 per month to obtain these medicines through private prescriptions.Conclusions This study establishes the feasibility of whole-plant medical cannabis as an effective and well-tolerated medicine for reducing seizure frequency in children suffering with intractable epilepsies. These findings justify the potential value of further research into the reported therapeutic benefit of whole-plant medicinal cannabis products.